Researchers have developed a method for statistically predicting impacts of climate change on outbreaks of tularemia in humans. New results show that tularemia may become increasingly common in the future in high-latitude regions.
Read moreResearchers have discovered that a key cell type involved in liver injury and cancer consists of two cellular families with different origins and functions.
Read moreResearchers have discovered new changes in blood samples associated with Alzheimer's disease. A new international study was conducted on disease-discordant Finnish twin pairs: one sibling suffering from Alzheimer's disease and the other being cognitively healthy. The researchers utilised the latest genome-wide methods to examine the twins' blood samples for any disease-related differences in epigenetic marks which are sensitive to changes in environmental factors. These differences between the siblings were discovered in multiple different genomic regions.
Read moreThe risk of febrile convulsions increases with the child's fever, and children who suffer from repeated febrile convulsions during their first year of life have an increased risk of developing epilepsy and psychiatric disorders later in life. This is shown by a comprehensive register-based study. In the study, almost 76,000 Danish children who have been suffering from febrile convulsions have been followed for more than 30 years.
Read moreCombining 2 different treatment methods to slow the progression of myopia may deliver better results than either can achieve on their own.
Read moreAn international team of researchers has developed new genetic-based epilepsy risk scores which may lay the foundation for a more personalized method of epilepsy diagnosis and treatment. This analysis is the largest study of epilepsy genetics to date, as well as the largest study of epilepsy using human samples.
Read moreResearchers report that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.
Read moreCurrent testing for Lyme disease, called the standard 2-tiered approach or the STT, involves running two complex assays (ELISA and western blot) to detect antibodies against the bacterium, and requires experienced personnel in a lab, and a few hours to carry out and interpret. Biomedical engineers have developed a rapid microfluidic test that can detect Lyme disease with similar performance as the STT in a much shorter time — 15 minutes.
Read morePopulation aging projections across the US show a divide between cities and rural areas, which could lead to pockets of vulnerability to climate change.
Read more